Holen Sie sich die Stockscreener-App
16.81
0.18%
-0.03
Schlusskurs vom Vortag:
$16.84
Offen:
$16.51
24-Stunden-Volumen:
210.67K
Relative Volume:
1.14
Marktkapitalisierung:
$485.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.94%
1M Leistung:
-0.06%
6M Leistung:
+33.94%
1J Leistung:
+21.55%
1-Tages-Spanne:
$16.35
$16.95
1-Wochen-Bereich:
$16.35
$17.45
52-Wochen-Spanne:
$10.55
$17.80
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Firmenname
Abrdn Life Sciences Investors
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie HQL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
16.81 | 486.21M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
10.13 | 3.76B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
36.30 | 3.25B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
22.79 | 2.79B | 0 | 0 | 0 | 0.00 |
|
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
14.98 | 2.35B | 0 | 0 | 0 | 0.00 |
|
GDV
Gabelli Dividend Income Trust
|
26.40 | 2.32B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Aktie (HQL) Neueste Nachrichten
Abrdn Life Sciences Investors To Go Ex-Dividend On November 21st, 2025 With 0.5 USD Dividend Per Share - 富途牛牛
Why Abrdn Life Sciences Investors stock is a value investor pickJuly 2025 Price Swings & Advanced Technical Analysis Signals - newser.com
abrdn Healthcare Investors $HQH Stake Raised by Allworth Financial LP - Defense World
Is abrdn Life Sciences Investors Shares stock expanding market penetrationDay Trade & Technical Pattern Based Signals - newser.com
How abrdn Life Sciences Investors Shares stock stacks up against competitorsMarket Volume Report & Detailed Earnings Play Strategies - newser.com
Abrdn Life Sciences Investors Q3 2025 Commentary (NYSE:HQL) - Seeking Alpha
Can Abrdn Life Sciences Investors stock withstand economic slowdownJuly 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
How institutional buying supports Abrdn Life Sciences Investors stockMarket Activity Recap & Entry Point Confirmation Signals - newser.com
What institutional flow reveals about Abrdn Life Sciences InvestorsPortfolio Risk Summary & Fast Entry Momentum Alerts - newser.com
Key resistance and support levels for Abrdn Life Sciences Investors2025 Risk Factors & Weekly Hot Stock Watchlists - newser.com
Reversal indicators forming on Abrdn Healthcare Investors stockMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Can abrdn Life Sciences Investors Shares stock ride next bull market cycle2025 Historical Comparison & Advanced Swing Trade Entry Plans - newser.com
Custom strategy builders for tracking Abrdn Life Sciences InvestorsEarnings Miss & Consistent Profit Trading Strategies - newser.com
Is Abrdn Life Sciences Investors stock ready for a breakoutJuly 2025 Setups & Daily Volume Surge Trade Alerts - newser.com
Does Abrdn Life Sciences Investors show high probability of rebound - newser.com
Will abrdn Life Sciences Investors Shares stock draw ESG focused fundsPortfolio Gains Summary & Daily Price Action Insights - newser.com
Is now a turning point for Abrdn Healthcare InvestorsCEO Change & Consistent Growth Equity Picks - newser.com
Why abrdn Life Sciences Investors Shares stock could rally stronglyMarket Activity Report & Low Risk Profit Maximizing Plans - newser.com
Is Abrdn Healthcare Investors stock overvalued by current metricsQuarterly Profit Report & Reliable Intraday Trade Alerts - newser.com
Will abrdn Healthcare Investors Shares of stock maintain strong growth2025 Trading Recap & Low Risk High Win Rate Picks - newser.com
What analysts say about Abrdn Life Sciences Investors stockFederal Reserve Announcements & Rapid Portfolio Expansion - earlytimes.in
What earnings revisions data tells us about Abrdn Life Sciences InvestorsProduct Launch & Daily Entry Point Alerts - newser.com
Finanzdaten der Abrdn Life Sciences Investors-Aktie (HQL)
Es liegen keine Finanzdaten für Abrdn Life Sciences Investors (HQL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.60%
1.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):